Recent News

• 03.27.2025 - Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.27.2025 - Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.10.2025 - Kyverna Therapeutics at Leerink Global Healthcare Conference
• 03.10.2025 - Kyverna Therapeutics at Leerink Global Healthcare Conference
• 03.03.2025 - Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference
• 03.03.2025 - Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference
• 01.21.2025 - Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer
• 01.21.2025 - Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer
• 01.14.2025 - Kyverna Therapeutics at J.P. Morgan Healthcare Conference
• 01.14.2025 - Kyverna Therapeutics at J.P. Morgan Healthcare Conference

Recent Filings

• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.24.2025 - 3 Initial statement of beneficial ownership of securities
• 01.21.2025 - EX-99.1 EX-99.1
• 01.21.2025 - 8-K Current report
• 01.13.2025 - EX-99.1 EX-99.1
• 01.13.2025 - 8-K Current report